| scholarly article | Q13442814 |
| P2093 | author name string | Padma V Devarajan | |
| Abdul Samad | |||
| Sharmila B Majee | |||
| Swati A Guhagarkar | |||
| P2860 | cites work | Evidence for receptor-mediated hepatic uptake of pullulan in rats | Q31966526 |
| Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells | Q33232325 | ||
| Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells | Q33269975 | ||
| Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications | Q34542168 | ||
| Nanoparticles in cancer therapy and diagnosis | Q34804817 | ||
| Engineered nanocarriers of doxorubicin: a current update | Q37186741 | ||
| Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. | Q37255427 | ||
| Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. | Q38290241 | ||
| Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. | Q38354946 | ||
| Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited | Q39911958 | ||
| Targeting of daunorubicin by association with DNA or proteins: a review. | Q40079286 | ||
| Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells | Q40389938 | ||
| Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo | Q40436193 | ||
| In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density | Q40821247 | ||
| Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. | Q40822661 | ||
| Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes | Q42824677 | ||
| Polyethylene sebacate–doxorubicin nanoparticles for hepatic targeting | Q42883191 | ||
| Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo. | Q43691927 | ||
| Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells. | Q43698391 | ||
| Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin | Q43918793 | ||
| Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake | Q44054856 | ||
| Liver targeting of human interferon-beta with pullulan based on metal coordination | Q44131188 | ||
| Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination | Q44167837 | ||
| Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes | Q45857706 | ||
| Polyethylene sebacate: genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. | Q46004495 | ||
| Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver | Q47758893 | ||
| Synthesis of cluster galactosides with high affinity for the hepatic asialoglycoprotein receptor | Q49187135 | ||
| Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. | Q54522306 | ||
| Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis | Q56998020 | ||
| Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice | Q68514006 | ||
| Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration | Q72057090 | ||
| Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier | Q73098482 | ||
| In vivo gene delivery to the liver using novel galactosylated cationic liposomes | Q73761281 | ||
| Targeting of Soybean-Derived Sterylglucoside Liposomes to Liver Tumors in Rat and Mouse Models | Q77087526 | ||
| Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine | Q77815020 | ||
| P433 | issue | 1-6 | |
| P921 | main subject | doxorubicin | Q18936 |
| nanoparticle | Q61231 | ||
| P304 | page(s) | 49-55 | |
| P577 | publication date | 2011-01-27 | |
| P1433 | published in | Cancer Nanotechnology | Q26853896 |
| P1476 | title | Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line | |
| P478 | volume | 2 |
| Q92462117 | In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy |
| Q47163185 | Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations |
| Q49372092 | Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide. |
| Q86953899 | Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand |
| Q101557486 | Surface receptor-mediated targeted drug delivery systems for enhanced cancer treatment: A state-of-the-art review |
| Q64886353 | Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. |
Search more.